XML 91 R80.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT AND GEOGRAPHIC INFORMATION - Segment Reporting Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting Information [Line Items]    
Total revenue, net $ 382,653 $ 368,872
Cost of goods sold 188,221 162,038
Research and development 24,728 26,965
Selling, general and administrative 181,497 165,798
Intangible asset amortization 3,704 10,107
Total cost and expenses 398,150 364,908
Operating (loss) income (15,497) 3,964
Interest income 4,420 5,040
Interest expense (18,815) (13,624)
Other income, net (144) (610)
Loss before income taxes (30,036) (5,230)
Codman Specialty Surgical    
Segment Reporting Information [Line Items]    
Total revenue, net 280,664 256,434
Tissue Technologies    
Segment Reporting Information [Line Items]    
Total revenue, net 101,989 112,438
Operating Segments | Codman Specialty Surgical    
Segment Reporting Information [Line Items]    
Total revenue, net 280,664 256,434
Cost of goods sold 92,682 92,973
Research and development 7,945 5,765
Selling, general and administrative 69,674 54,204
Intangible asset amortization 0 0
Total cost and expenses 170,301 152,942
Operating (loss) income 110,363 103,492
Operating Segments | Tissue Technologies    
Segment Reporting Information [Line Items]    
Total revenue, net 101,989 112,438
Cost of goods sold 45,063 37,538
Research and development 3,719 4,901
Selling, general and administrative 37,161 39,333
Intangible asset amortization 0 0
Total cost and expenses 85,943 81,772
Operating (loss) income 16,046 30,666
Corporate and Other    
Segment Reporting Information [Line Items]    
Total revenue, net 0 0
Cost of goods sold 50,476 31,527
Research and development 13,064 16,299
Selling, general and administrative 74,662 72,261
Intangible asset amortization 3,704 10,107
Total cost and expenses 141,906 130,194
Operating (loss) income $ (141,906) $ (130,194)